$NUTX Income Statement | Understand Stock

$NUTX

$208.25 -$0.75 (0.36%) Close

$NUTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Capitation revenue, net
SaaS revenue
Management service revenue, net
Revenue
Hospital division
Population health management division
Total revenue
Cost of sales
Operating costs and expenses:
Payroll
Contract services
Medical supplies
Insurance expense
Depreciation and amortization
Other
Total operating costs and expenses

Gross profit
Corporate and other costs:
Research and development
Sales and marketing
Facilities closing costs
Acquisition costs
Stock-based compensation
Impairment of assets
Impairment of goodwill
Gain on sale of assets
Gain on lease termination
Loss on sale of fixed assets
Amortization
General and administrative expenses
Total corporate and other costs

Operating income (loss)
Loss on extinguishment of debt
Settlement payment from ACMG
Income from forgiveness of debt
Impairment of Series E investment
Interest income
Interest expense – debt obligation
Interest expense – accretion of debt discount
Interest expense, net
Loss on warrant liability
Other (income) expense
Income (loss) before taxes
Income tax expense (benefit)
Loss from discontinued operations (including gain on disposal of $142,027 for the year ended December 31, 2020)
Net income (loss)
Less: net income attributable to noncontrolling interests
Net income (loss) attributable to Clinigence Holdings, Inc.
Net income (loss) attributable to Nutex Health Inc.
Earnings (loss) per common share
Continuing operations
Discontinued operations
Net income (loss) per common share
Weighted average common shares outstanding - basic and fully diluted
Basic earnings (loss) per common share (in dollars per share)
Diluted earnings (loss) per common share (in dollars per share)

Comments